June 20-25, 2010 • Honolulu, Hawai’i
47
islh 2013 • MAY 10-12
SATURDAY AM POSTER SESSION
P214
Current Laboratory Practices in
the Diagnosis and Management of
Haemophilia: Results of an international
survey
Steve Kitchen
1
,
Kira Signer
2
,
Nigel Key
3
1
Dept of Coagulation, Royal Hallamshire
Hospital, Sheffield, United Kingdom,
2
PSL
Research, London, United Kingdom,
3
Hemophilia and Thrombosis Centre, UNC,
Chapel Hill, United States
P216
Influence of Antithrombin Deficiency and
Elevated Factor VIII on Heparin Activity
Measured by APTT and Anti-Factor Xa
Assay in Vitro
Vadim Kostousov
1,2
,
Kim Nguyen
1
,
Jun
Teruya
1,2
1
Texas Children’s Hospital, BCM, Houston,
TX, United States,
2
Baylor College of
Medicine, Houston, TX, United States
P218
Factor XIII Diagnostic Testing: A
Retrospective Analysis of One Center’s
Experience
Karen A. Moffat
1,2
,
Catherine P.M. Hayward
1,2,3
1
Hamilton Regional Laboratory Medicine
Program, Hamilton, ON, Canada,
2
Department
of Medicine, McMaster University, Hamilton,
ON, Canada,
3
Department of Pathology and
Molecular Medicine, Hamilton, ON, Canada
P220
Clinicopathologic Characteristics of
Positive and Indeterminate Lupus
Anticoagulant Testing in Children
Ana Ruano, Megan Nakashima, Kandice
Kottke-Marchant, Heesun Rogers
Cleveland Clinic Foundation, Cleveland, OH,
United States
P222
Evaluation of an Anti Xa method for
assay of Rivaroxaban and relationship to
Prothrombin time in ‘ex vivo’ samples
Julie Smith, Joost van Veen, Steve Kitchen,
Eddie Hampton, Mike Makris, Rhona Maclean
Dept of Coagulation, Sheffield Teaching
Hospitals, SHEFFIELD, United Kingdom
P224
Elevated C-Reactive ProteinMay Result
in Misinterpretation of the PTT 1:1 Mixing
Study
Jun Teruya, Kim Nguyen, Sridevi Devaraj, Lisa
Bomgaars, Vadim Kostousov
Texas Children’s Hospital, Houston, TX,
United States
P226
Evaluation of a new liquid ready-to-use
thrombin time reagent (DG-TT L Human)
automated on the Q hemostasis analyzer.
Pierre Toulon, Sylvain Buvat, Florence
Fischer, Anny Appert-Flory, Didier Jambou
Hematology, Pasteur University Hospital,
Nice, France
P228
Does the concentration of von Willebrand
factor in factor VIII deficient plasma
influence the factor VIII level in plasma
samples from Hemophilia A patients?
Laurence VERDICKT, Dominique LATINNE,
Stéphane EECKHOUDT
Cliniques universitaires Saint Luc, Brussels,
Belgium
